Efficacy and safety of basic fibroblast growth factor (bFGF) related decapeptide solution plus Tacrolimus 0.1% ointment versus Tacrolimus 0.1% ointment in the treatment of stable vitiligo.
Shah, Bela
Efficacy and safety of basic fibroblast growth factor (bFGF) related decapeptide solution plus Tacrolimus 0.1% ointment versus Tacrolimus 0.1% ointment in the treatment of stable vitiligo. [electronic resource] - Dermatologic therapy 11 2019 - e13109 p. digital
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
1529-8019
10.1111/dth.13109 doi
Adult
Drug Therapy, Combination
Female
Fibroblast Growth Factor 2--administration & dosage
Humans
Male
Middle Aged
Ointments
Oligopeptides--administration & dosage
Prospective Studies
Solutions
Tacrolimus--administration & dosage
Vitiligo--drug therapy
Efficacy and safety of basic fibroblast growth factor (bFGF) related decapeptide solution plus Tacrolimus 0.1% ointment versus Tacrolimus 0.1% ointment in the treatment of stable vitiligo. [electronic resource] - Dermatologic therapy 11 2019 - e13109 p. digital
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
1529-8019
10.1111/dth.13109 doi
Adult
Drug Therapy, Combination
Female
Fibroblast Growth Factor 2--administration & dosage
Humans
Male
Middle Aged
Ointments
Oligopeptides--administration & dosage
Prospective Studies
Solutions
Tacrolimus--administration & dosage
Vitiligo--drug therapy